Fiorino, F.; Sicuranza, A.; Ciabattini, A.; Santoni, A.; Pastore, G.; Simoncelli, M.; Polvere, J.; Galimberti, S.; Auddino, S.; Baratè, C.;
et al. The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose. Biomedicines 2021, 9, 1480.
https://doi.org/10.3390/biomedicines9101480
AMA Style
Fiorino F, Sicuranza A, Ciabattini A, Santoni A, Pastore G, Simoncelli M, Polvere J, Galimberti S, Auddino S, Baratè C,
et al. The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose. Biomedicines. 2021; 9(10):1480.
https://doi.org/10.3390/biomedicines9101480
Chicago/Turabian Style
Fiorino, Fabio, Anna Sicuranza, Annalisa Ciabattini, Adele Santoni, Gabiria Pastore, Martina Simoncelli, Jacopo Polvere, Sara Galimberti, Stefano Auddino, Claudia Baratè,
and et al. 2021. "The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose" Biomedicines 9, no. 10: 1480.
https://doi.org/10.3390/biomedicines9101480
APA Style
Fiorino, F., Sicuranza, A., Ciabattini, A., Santoni, A., Pastore, G., Simoncelli, M., Polvere, J., Galimberti, S., Auddino, S., Baratè, C., Montagnani, F., Sammartano, V., Bocchia, M., & Medaglini, D.
(2021). The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose. Biomedicines, 9(10), 1480.
https://doi.org/10.3390/biomedicines9101480
